Lan Chen

Opex Controller Of Biologics IA Groups, Rare Disease Business Unit

Lan Chen is an accomplished finance professional with extensive experience in global manufacturing and supply finance, currently serving as a Senior Manager at Takeda since August 2022. Previously held the position of Opex Controller at Sanofi for the Biologics IA groups within the Rare Disease Business Unit and worked as a Principal Financial Analyst at Boston Scientific, where significant contributions included leading budgets, financial planning processes, and collaborating with IT operations. Experience also includes serving as a Senior Financial Analyst at National Grid and Hewlett-Packard, where financial support for IT projects and pricing analysis were key responsibilities. Lan Chen holds a Master of Business Administration in Finance from the Kelly School of Business at Indiana University.

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices